| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 301-309, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
E Campo, J Munoz, R Miquel, A Palacin, A Cardesa, BF Sloane and MR Emmert-Buck
Laboratory of Anatomic Pathology, Hospital Clinico Provincial, University of Barcelona, Spain.
Cathepsin B is a lysosomal cysteine proteinase that has the ability to degrade several extracellular matrix components at both neutral and acidic pH and has been implicated in the progression of several human and rodent tumors. We have studied the expression of cathepsin B in human colorectal tissues using a monospecific polyclonal rabbit antibody raised against human liver cathepsin B. In immunoblots of normal and neoplastic colorectal tissues this antibody specifically recognized only cathepsin B. We studied 101 cases of formalin-fixed, paraffin-embedded tissue (15 normal mucosa, 17 adenomas, and 69 carcinomas). Epithelial cells of normal mucosa and adenomas were either negative or showed a weak granular reactivity located in the paranuclear and apical cytoplasm of superficial cells. Small clusters of histiocytes were also positive in the region of the superficial area of the lamina propria. In carcinomas, increased expression of cathepsin B correlated with advanced stage of the disease. Increased immunoreactivity of cathepsin B in malignant cells was associated with either a diffuse cytoplasmic staining or was polarized to the basal pole of the cells. This is in contrast to the punctate paranuclear staining pattern observed in normal colonic mucosal cells. In tumor stromal cells, increased expression of the enzyme correlated with neoplastic progression. Expression of high levels of cathepsin B in the tumor epithelial cells was associated with a significantly shorter survival of the patients. In conclusion, our results indicate that cathepsin B expression is up-regulated in human colorectal carcinomas compared with normal mucosa and adenomas and correlates with tumor progression.
This article has been cited by other articles:
![]() |
O. Vasiljeva, A. Papazoglou, A. Kruger, H. Brodoefel, M. Korovin, J. Deussing, N. Augustin, B. S. Nielsen, K. Almholt, M. Bogyo, et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res., May 15, 2006; 66(10): 5242 - 5250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cavallo-Medved, J. Mai, J. Dosescu, M. Sameni, and B. F. Sloane Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells J. Cell Sci., April 1, 2005; 118(7): 1493 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bien, C. A. Ritter, M. Gratz, B. Sperker, J. Sonnemann, J. F. Beck, and H. K. Kroemer Nuclear Factor-{kappa}B Mediates Up-Regulation of Cathepsin B by Doxorubicin in Tumor Cells Mol. Pharmacol., May 1, 2004; 65(5): 1092 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
Imaging Proteolysis in Living Organotypic Models of Cancer: BONNIE F. SLOANE, MANSOUREH SAMENI, STEFANIE ROSHY, IZABELA PODGORSKI, JULIE DOSESCU, BRUCE LINEBAUGH, MICHAEL CHER, AND KAMIAR MOIN, Departments of Pharmacology, Urology and Pathology, Wayne State University and Proteases and Cancer Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan 48201 Toxicol Pathol, January 1, 2004; 32(1): 152 - 153. [PDF] |
||||
![]() |
U. Mahmood and R. Weissleder Near-Infrared Optical Imaging of Proteases in Cancer Mol. Cancer Ther., May 1, 2003; 2(5): 489 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Koblinski, J. Dosescu, M. Sameni, K. Moin, K. Clark, and B. F. Sloane Interaction of Human Breast Fibroblasts with Collagen I Increases Secretion of Procathepsin B J. Biol. Chem., August 23, 2002; 277(35): 32220 - 32227. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. M. Hazen, F. E. Bleeker, B. Lauritzen, S. Bahns, J. Song, A. Jonker, B. E. M. Van Driel, H. Lyon, U. Hansen, A. Köhler, et al. Comparative Localization of Cathepsin B Protein and Activity in Colorectal Cancer J. Histochem. Cytochem., October 1, 2000; 48(10): 1421 - 1430. [Abstract] [Full Text] |
||||
![]() |
J. Mai, R. L. Finley Jr., D. M. Waisman, and B. F. Sloane Human Procathepsin B Interacts with the Annexin II Tetramer on the Surface of Tumor Cells J. Biol. Chem., April 21, 2000; 275(17): 12806 - 12812. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lin, S. Aggarwal, T. W. Glover, M. B. Orringer, S. Hanash, and D. G. Beer A Minimal Critical Region of the 8p22-23 Amplicon in Esophageal Adenocarcinomas Defined Using Sequence Tagged Site-Amplification Mapping and Quantitative Polymerase Chain Reaction Includes the GATA-4 Gene Cancer Res., March 1, 2000; 60(5): 1341 - 1347. [Abstract] [Full Text] |
||||
![]() |
P. Strojan, M. Budihna, L. Smid, B. Svetic, I. Vrhovec, J. Kos, and J. Skrk Prognostic Significance of Cysteine Proteinases Cathepsins B and L and Their Endogenous Inhibitors Stefins A and B in Patients with Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., March 1, 2000; 6(3): 1052 - 1062. [Abstract] [Full Text] |
||||
![]() |
S. Krueger, C. Haeckel, F. Buehling, and A. Roessner Inhibitory Effects of Antisense Cathepsin B cDNA Transfection on Invasion and Motility in a Human Osteosarcoma Cell Line Cancer Res., December 1, 1999; 59(23): 6010 - 6014. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Strojnik, J. Kos, B. Zidanik, R. Golouh, and T. Lah Cathepsin B Immunohistochemical Staining in Tumor and Endothelial Cells Is a New Prognostic Factor for Survival in Patients with Brain Tumors Clin. Cancer Res., March 1, 1999; 5(3): 559 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abdollahi, L. A. Getts, G. Sonoda, P. D. Miller, T. Taguchi, A. K. Godwin, J. R. Testa, and T. C. Hamilton Genome Scanning Detects Amplification of the Cathepsin B Gene (CtsB) in Transformed Rat Ovarian Surface Epithelial Cells Reproductive Sciences, January 1, 1999; 6(1): 32 - 40. [Abstract] [PDF] |
||||
![]() |
S. J. Hughes, T. W. Glover, X.-X. Zhu, R. Kuick, D. Thoraval, M. B. Orringer, D. G. Beer, and S. Hanash A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma PNAS, October 13, 1998; 95(21): 12410 - 12415. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Calkins, M. Sameni, J. Koblinski, B. F. Sloane, and K. Moin Differential Localization of Cysteine Protease Inhibitors and a Target Cysteine Protease, Cathepsin B, by Immuno-Confocal Microscopy J. Histochem. Cytochem., June 1, 1998; 46(6): 745 - 752. [Abstract] [Full Text] |
||||
![]() |
C. A. Iacobuzio-Donahue, S. Shuja, J. Cai, P. Peng, and M. J. Murnane Elevations in Cathepsin B Protein Content and Enzyme Activity Occur Independently of Glycosylation during Colorectal Tumor Progression J. Biol. Chem., November 14, 1997; 272(46): 29190 - 29199. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yan, X. Deng, M. Chen, Y. Xu, M. Ahram, B. F. Sloane, and E. Friedman Oncogenic c-Ki-ras but Not Oncogenic c-Ha-ras Up-regulates CEA Expression and Disrupts Basolateral Polarity in Colon Epithelial Cells J. Biol. Chem., October 31, 1997; 272(44): 27902 - 27907. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |